Tg Therapeutics earnings were $95.7M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest TGTX earnings report on Jun 30, 2024 announced Q2 2024 earnings of $6.9M, down 164.2% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, TGTX reported annual earnings of $12.7M, with -106.4% growth. The next TGTX earnings date is Oct 30, 2024.
What were Tg Therapeutics's earnings last quarter?
On TGTX's earnings call on Invalid Date, Tg Therapeutics (NASDAQ: TGTX) reported Q2 2024 earnings per share (EPS) of $0.05, up 114.71% year over year. Total TGTX earnings for the quarter were $6.88 million. In the same quarter last year, Tg Therapeutics's earnings per share (EPS) was -$0.34.
The next TGTX earnings call is Invalid Date. Add TGTX to your watchlist to be reminded of Tg Therapeutics's next earnings date.
What was TGTX's earnings growth in the past year?
As of Tg Therapeutics's earnings date in Invalid Date, Tg Therapeutics's earnings has grown year over year. TGTX earnings in the past year totalled $95.69 million.
Is Tg Therapeutics profitable or losing money?
As of the last Tg Therapeutics earnings report, Tg Therapeutics is currently profitable. Tg Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2024 was $95.69 million, a 154.47% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.